Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/21645515.2021.1911204 http://scihub22266oqcxt.onion/10.1080/21645515.2021.1911204 34033528!8381795!34033528     free     free     free       Hum+Vaccin+Immunother 2021 ; 17 (9): 2873-2893 Nephropedia Template TP {{tp|p=34033528|t=2021. COVID-19 vaccine platforms: Delivering on a promise?|pdf=|usr=}}{{34033528}} gab.com Text COVID-19 vaccine platforms: Delivering on a promise JO: Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=34033528 #FOAvip The emergence of the novel SARS-CoV-2 and COVID-19 has brought into sharp focus the need for a vaccine to prevent this disease. Vaccines have saved millions of lives since their introduction to the public over 200 years ago. The potential for vaccination reached new heights in the mid-20th century with the development of technologies that expanded the ability to create novel vaccines. Since then, there has been continued technological advancement in vaccine development. The resulting platforms provide the promise for solutions for many infectious diseases, including those that have been with us for decades as well as those just now emerging. Each vaccine platform represents a different technology with a unique set of advantages and challenges, especially when considering manufacturing. Therefore, it is essential to understand each platform as a separate product and process with its specific quality considerations. This review outlines the relevant platforms for developing a vaccine for SARS-CoV-2 and discusses the advantages and disadvantages of each. Twit Text FOAVip COVID-19 vaccine platforms: Delivering on a promise ????Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=34033528 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34033528 #FOAvip English Wikipedia <ref>{{Cite pmid|34033528}}</ref> COVID-19 vaccine platforms: Delivering on a promise? #MMPMID34033528 Verdecia M; Kokai-Kun JF; Kibbey M; Acharya S; Venema J; Atouf F Hum Vaccin Immunother 2021[Sep]; 17 (9): 2873-2893 PMID34033528show ga The emergence of the novel SARS-CoV-2 and COVID-19 has brought into sharp focus the need for a vaccine to prevent this disease. Vaccines have saved millions of lives since their introduction to the public over 200 years ago. The potential for vaccination reached new heights in the mid-20th century with the development of technologies that expanded the ability to create novel vaccines. Since then, there has been continued technological advancement in vaccine development. The resulting platforms provide the promise for solutions for many infectious diseases, including those that have been with us for decades as well as those just now emerging. Each vaccine platform represents a different technology with a unique set of advantages and challenges, especially when considering manufacturing. Therefore, it is essential to understand each platform as a separate product and process with its specific quality considerations. This review outlines the relevant platforms for developing a vaccine for SARS-CoV-2 and discusses the advantages and disadvantages of each. |*COVID-19[MESH] |*Vaccines[MESH] |COVID-19 Vaccines[MESH] |Humans[MESH] |SARS-CoV-2[MESH]COVID-19 vaccine platforms: Delivering on a promise?(epmc).pdf DeepDyve Pubget Overpricing